NRx Pharmaceuticals Inc. (NRXPW)
0.10
-0.00 (-3.61%)
At close: Mar 03, 2025, 9:30 AM
No 1D chart data available
| Bid | 0.08 |
| Market Cap | 38.4M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -6.247 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.11 |
| Volume | 48 |
| Avg. Volume (20D) | 18,963.41 |
| Open | 0.10 |
| Previous Close | 0.10 |
| Day's Range | 0.06 - 0.11 |
| 52-Week Range | 0.10 - 0.10 |
| Beta | 1.12 |
About NRXPW
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 1, 2017
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Website https://www.nrxpharma.com